Former Turing Pharmaceuticals CEO Martin Shkreli attends the House Committee on Oversight and Reform Committee hearing on Capitol Hill in Washington, Feb. 4, 2016. A federal judge on Friday, Jan. 14, 2022 ordered Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. (AP Photo/Susan Walsh, File)
Rookie QB Daniels stars again in desert return, Commanders beat Cardinals 42-14 for 3rd straight Shares
Rescuers race to free people trapped by Hurricane Helene after storm kills at least 40 in 4 states Shares